Skip to main content
. 2018 Jan 11;29(3):669–680. doi: 10.1093/annonc/mdx797

Figure 1.

Figure 1.

Figure 1.

Kaplan–Meier plots of progression-free survival in patients in the PALOMA-3 study with visceral metastases (A), nonvisceral metastases (B), and bone-only disease (C), as well as in patients in the PALOMA-2 study with visceral metastases (D), nonvisceral metastases (E), and bone-only disease (F). HR, hazard ratio; NE, not estimable; NR, not reached.